Researchers Submit Patent Application, "Compositions And Methods For Treating And Preventing Interstitial Cystitis", for Approval (USPTO 20240277700).

A patent application has been submitted for a method of treating and preventing interstitial cystitis, a chronic inflammatory disorder of the bladder. The method involves administering both an H1 receptor antagonist and an H2 receptor antagonist to the patient. The inventors propose that this dual histamine receptor blockade can effectively reduce inflammation and alleviate symptoms associated with interstitial cystitis. The patent application provides details on the specific medications that can be used and the dosage forms for administration. [Extracted from the article]